TrialThe Journal of investigative dermatology2020

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).

Joel M Gelfand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.